17-alpha-hydroxyprogesterone and Sertoli Cell Tumor

17-alpha-hydroxyprogesterone has been researched along with Sertoli Cell Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Déchaud, H; Dutrieux-Berger, N; Pascale, MM; Pugeat, M; Roberts, M; Rousset, H; Tourniaire, J	1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Sertoli Cell Tumor

Article	Year
Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clinical endocrinology, 1994, Volume: 41, Issue:5 Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cell Tumor; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Ovarian Neoplasms; Sertoli Cell Tumor; Testosterone; Virilism	1994

Article

Year

Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.

Clinical endocrinology, 1994, Volume: 41, Issue:5

Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cell Tumor; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Ovarian Neoplasms; Sertoli Cell Tumor; Testosterone; Virilism

1994